APO Research
Talk to an analyst

APO RESEARCH · REPORT

Allergy Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Allergy Vaccine Market Outlook and Growth Opportunities 2026

2 January 2026196 pages

Choose your research edition.

Industry ResearchAllergy Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Allergy Vaccine Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Allergy Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Allergy Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Allergy Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Allergy Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Allergy Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Allergy Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Allergy Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Allergy Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Allergy Vaccine market include ALK-Abello, Allergy Therapeutics, HAL, Holister Stier, Leti, Stallergenes Greer, WOLW Pharma and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Allergy Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Allergy Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Allergy Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Allergy Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Allergy Vaccine Segment by Company

ALK-Abello

Allergy Therapeutics

HAL

Holister Stier

Leti

Stallergenes Greer

WOLW Pharma

Merck

Allergy Vaccine Segment by Type

Subcutaneous Immunotherapy

Sublingual Immunotherapy

Allergy Vaccine Segment by Application

Allergic Rhinitis

Allergic Asthma

Other

Allergy Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Allergy Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Allergy Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Allergy Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Allergy Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergy Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Allergy Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergy Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Allergy Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Allergy Vaccine industry.

Chapter 3: Detailed analysis of Allergy Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Allergy Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Allergy Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Allergy Vaccine Industry Trends Table 2. Allergy Vaccine Industry Drivers Table 3. Allergy Vaccine Industry Opportunities and Challenges Table 4. Allergy Vaccine Industry Restraints Table 5. Global Allergy Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Allergy Vaccine Revenue Share by Company (2021-2026) Table 7. Global Allergy Vaccine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Allergy Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Allergy Vaccine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Allergy Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Allergy Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Allergy Vaccine Company, Product Type & Application Table 13. Global Allergy Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Allergy Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Subcutaneous Immunotherapy Table 18. Significant Companies of Sublingual Immunotherapy Table 19. Global Allergy Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Allergy Vaccine Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Allergy Vaccine Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Allergy Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Allergy Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Allergy Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Allergy Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Allergy Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Allergy Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Allergy Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Allergic Rhinitis Table 30. Significant Companies of Allergic Asthma Table 31. Significant Companies of Other Table 32. Global Allergy Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Allergy Vaccine Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Allergy Vaccine Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Allergy Vaccine Sales Volume Share by Application (2021-2026) Table 36. Global Allergy Vaccine Sales Volume Share by Application (2027-2032) Table 37. Global Allergy Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Allergy Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Allergy Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Allergy Vaccine Sales Value Share by Application (2021-2026) Table 41. Global Allergy Vaccine Sales Value Share by Application (2027-2032) Table 42. Global Allergy Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Allergy Vaccine Sales by Region (2021-2026) & (K Units) Table 44. Global Allergy Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Allergy Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Allergy Vaccine Sales Market Share by Region (2027-2032) Table 47. Global Allergy Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Allergy Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Allergy Vaccine Sales Value Share by Region (2021-2026) Table 50. Global Allergy Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Allergy Vaccine Sales Value Share by Region (2027-2032) Table 52. Global Allergy Vaccine Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Allergy Vaccine Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Allergy Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Allergy Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Allergy Vaccine Sales by Country (2021-2026) & (K Units) Table 57. Global Allergy Vaccine Sales Market Share by Country (2021-2026) Table 58. Global Allergy Vaccine Sales by Country (2027-2032) & (K Units) Table 59. Global Allergy Vaccine Sales Market Share by Country (2027-2032) Table 60. Global Allergy Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Allergy Vaccine Sales Value Market Share by Country (2021-2026) Table 62. Global Allergy Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Allergy Vaccine Sales Value Market Share by Country (2027-2032) Table 64. ALK-Abello Company Information Table 65. ALK-Abello Business Overview Table 66. ALK-Abello Allergy Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. ALK-Abello Allergy Vaccine Product Portfolio Table 68. ALK-Abello Recent Development Table 69. Allergy Therapeutics Company Information Table 70. Allergy Therapeutics Business Overview Table 71. Allergy Therapeutics Allergy Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Allergy Therapeutics Allergy Vaccine Product Portfolio Table 73. Allergy Therapeutics Recent Development Table 74. HAL Company Information Table 75. HAL Business Overview Table 76. HAL Allergy Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. HAL Allergy Vaccine Product Portfolio Table 78. HAL Recent Development Table 79. Holister Stier Company Information Table 80. Holister Stier Business Overview Table 81. Holister Stier Allergy Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Holister Stier Allergy Vaccine Product Portfolio Table 83. Holister Stier Recent Development Table 84. Leti Company Information Table 85. Leti Business Overview Table 86. Leti Allergy Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Leti Allergy Vaccine Product Portfolio Table 88. Leti Recent Development Table 89. Stallergenes Greer Company Information Table 90. Stallergenes Greer Business Overview Table 91. Stallergenes Greer Allergy Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Stallergenes Greer Allergy Vaccine Product Portfolio Table 93. Stallergenes Greer Recent Development Table 94. WOLW Pharma Company Information Table 95. WOLW Pharma Business Overview Table 96. WOLW Pharma Allergy Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. WOLW Pharma Allergy Vaccine Product Portfolio Table 98. WOLW Pharma Recent Development Table 99. Merck Company Information Table 100. Merck Business Overview Table 101. Merck Allergy Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Merck Allergy Vaccine Product Portfolio Table 103. Merck Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Allergy Vaccine Distributors List Table 107. Allergy Vaccine Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Allergy Vaccine Product Image Figure 2. Global Allergy Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Allergy Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Allergy Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Allergy Vaccine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Allergy Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Subcutaneous Immunotherapy Image Figure 10. Sublingual Immunotherapy Image Figure 11. Global Allergy Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Allergy Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Allergy Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Allergy Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Allergy Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Allergy Vaccine Sales Value Share by Type (2021-2032) Figure 17. Allergic Rhinitis Image Figure 18. Allergic Asthma Image Figure 19. Other Image Figure 20. Global Allergy Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Allergy Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Allergy Vaccine Sales Volume Share by Application (2021-2032) Figure 23. Global Allergy Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Allergy Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Allergy Vaccine Sales Value Share by Application (2021-2032) Figure 26. Global Allergy Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Allergy Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Allergy Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Allergy Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Allergy Vaccine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Allergy Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Allergy Vaccine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Allergy Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Allergy Vaccine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Allergy Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Allergy Vaccine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Allergy Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Allergy Vaccine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Allergy Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Allergy Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Allergy Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Allergy Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Allergy Vaccine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Allergy Vaccine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Subcutaneous Immunotherapy
  • Sublingual Immunotherapy
Applications
  • Allergic Rhinitis
  • Allergic Asthma
  • Other
Companies covered
  • ALK-Abello
  • Allergy Therapeutics
  • HAL
  • Holister Stier
  • Leti
  • Stallergenes Greer
  • WOLW Pharma
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Allergy Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Allergy Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Allergy Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Allergy Vaccine Market Dynamics
  1. 2.1 Allergy Vaccine Industry Trends
  2. 2.2 Allergy Vaccine Industry Drivers
  3. 2.3 Allergy Vaccine Industry Opportunities and Challenges
  4. 2.4 Allergy Vaccine Industry Restraints
3 Allergy Vaccine Market by Company
  1. 3.1 Global Allergy Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Allergy Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Allergy Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Allergy Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Allergy Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Allergy Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Allergy Vaccine Company Product Type and Application
  8. 3.8 Global Allergy Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Allergy Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Allergy Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Allergy Vaccine Market by Type
  1. 4.1 Allergy Vaccine Type Introduction
  2. 4.1.1 Subcutaneous Immunotherapy
  3. 4.1.2 Sublingual Immunotherapy
  4. 4.2 Global Allergy Vaccine Sales Volume by Type
  5. 4.2.1 Global Allergy Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Allergy Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Allergy Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Allergy Vaccine Sales Value by Type
  9. 4.3.1 Global Allergy Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Allergy Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Allergy Vaccine Sales Value Share by Type (2021-2032)
5 Allergy Vaccine Market by Application
  1. 5.1 Allergy Vaccine Application Introduction
  2. 5.1.1 Allergic Rhinitis
  3. 5.1.2 Allergic Asthma
  4. 5.1.3 Other
  5. 5.2 Global Allergy Vaccine Sales Volume by Application
  6. 5.2.1 Global Allergy Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Allergy Vaccine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Allergy Vaccine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Allergy Vaccine Sales Value by Application
  10. 5.3.1 Global Allergy Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Allergy Vaccine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Allergy Vaccine Sales Value Share by Application (2021-2032)
6 Allergy Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Allergy Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Allergy Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Allergy Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Allergy Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Allergy Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Allergy Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Allergy Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Allergy Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Allergy Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Allergy Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Allergy Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Allergy Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Allergy Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Allergy Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Allergy Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Allergy Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Allergy Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Allergy Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Allergy Vaccine Sales Value Share by Country, 2025 VS 2032
7 Allergy Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Allergy Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Allergy Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Allergy Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Allergy Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Allergy Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Allergy Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Allergy Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Allergy Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Allergy Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Allergy Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Allergy Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Allergy Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Allergy Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Allergy Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Allergy Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Allergy Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Allergy Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Allergy Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Allergy Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Allergy Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Allergy Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Allergy Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Allergy Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Allergy Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Allergy Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Allergy Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Allergy Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Allergy Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Allergy Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Allergy Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Allergy Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Allergy Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Allergy Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Allergy Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Allergy Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Allergy Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Allergy Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Allergy Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ALK-Abello
  2. 8.1.1 ALK-Abello Company Information
  3. 8.1.2 ALK-Abello Business Overview
  4. 8.1.3 ALK-Abello Allergy Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 ALK-Abello Allergy Vaccine Product Portfolio
  6. 8.1.5 ALK-Abello Recent Developments
  7. 8.2 Allergy Therapeutics
  8. 8.2.1 Allergy Therapeutics Company Information
  9. 8.2.2 Allergy Therapeutics Business Overview
  10. 8.2.3 Allergy Therapeutics Allergy Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Allergy Therapeutics Allergy Vaccine Product Portfolio
  12. 8.2.5 Allergy Therapeutics Recent Developments
  13. 8.3 HAL
  14. 8.3.1 HAL Company Information
  15. 8.3.2 HAL Business Overview
  16. 8.3.3 HAL Allergy Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 HAL Allergy Vaccine Product Portfolio
  18. 8.3.5 HAL Recent Developments
  19. 8.4 Holister Stier
  20. 8.4.1 Holister Stier Company Information
  21. 8.4.2 Holister Stier Business Overview
  22. 8.4.3 Holister Stier Allergy Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Holister Stier Allergy Vaccine Product Portfolio
  24. 8.4.5 Holister Stier Recent Developments
  25. 8.5 Leti
  26. 8.5.1 Leti Company Information
  27. 8.5.2 Leti Business Overview
  28. 8.5.3 Leti Allergy Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Leti Allergy Vaccine Product Portfolio
  30. 8.5.5 Leti Recent Developments
  31. 8.6 Stallergenes Greer
  32. 8.6.1 Stallergenes Greer Company Information
  33. 8.6.2 Stallergenes Greer Business Overview
  34. 8.6.3 Stallergenes Greer Allergy Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Stallergenes Greer Allergy Vaccine Product Portfolio
  36. 8.6.5 Stallergenes Greer Recent Developments
  37. 8.7 WOLW Pharma
  38. 8.7.1 WOLW Pharma Company Information
  39. 8.7.2 WOLW Pharma Business Overview
  40. 8.7.3 WOLW Pharma Allergy Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 WOLW Pharma Allergy Vaccine Product Portfolio
  42. 8.7.5 WOLW Pharma Recent Developments
  43. 8.8 Merck
  44. 8.8.1 Merck Company Information
  45. 8.8.2 Merck Business Overview
  46. 8.8.3 Merck Allergy Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Merck Allergy Vaccine Product Portfolio
  48. 8.8.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Allergy Vaccine Value Chain Analysis
  2. 9.1.1 Allergy Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Allergy Vaccine Sales Mode & Process
  6. 9.2 Allergy Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Allergy Vaccine Distributors
  9. 9.2.3 Allergy Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst